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Abstract 
 
Over the last several decades, the relative contribution of early life events to individual disease 
susceptibility has been explored extensively. Only fairly recently, however, has it become 
evident that abnormal or excessive nociceptive activity experienced during the perinatal period 
may permanently alter the normal development of the CNS and influence future responses to 
somatosensory input. Given the significant rise in the number of premature infants receiving 
high‐technology intensive care over the last twenty years, ex‐preterm neonates may be 
exceedingly vulnerable to the long‐term effects of repeated invasive interventions. The present 
review summarizes available clinical and laboratory findings on the lasting impact of exposure 
to noxious stimulation during early development, with a focus on the structural and functional 
alterations in nociceptive circuits, and its sexually dimorphic impact. 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Premature Birth and Neonatal Intensive Care 
Advances in perinatal medical care over the last two decades have substantially increased the 
survival of infants born premature [1]. As part of this life‐saving care, however, preterm 
neonates are exposed to multiple invasive procedures in the neonatal intensive care unit (NICU) 
which are frequently accompanied by local inflammation and tissue damage lasting for several 
hours to days [2]. Growing clinical and basic science data suggests that exposure to repeated 
tissue damaging interventions in neonates may induce lasting changes in the CNS and have 
profound consequences for subsequent nociceptive processing [3; 4; 5; 6; 7; 8; 9; 10].  
Premature birth, defined as birth prior to 37 weeks gestation, occurs at alarmingly high rates 
worldwide. According to the World Health Organization, 16.5% of all infants are born 
premature, with over 500,000 preterm babies born each year in the United States alone [11]. 
Indeed, the rates of premature births in the United States have been escalating steadily to 
nearly 35% of all live births within the last two decades [11]. While the underlying causes of 
prematurity are diverse and not completely understood, several factors are known to 
contribute to the increased prevalence of preterm births, including assisted reproductive 
techniques [11], tobacco, alcohol and illicit drug use during pregnancy [12], as well as high 
maternal blood pressure, diabetes and obesity [13].   
Intrinsic to their care in the NICU, preterm infants undergo on average 14 noxious (painful 
and/or tissue damaging) procedures per day including repeated heel lances, endotracheal 
intubation, surgery, and respiratory and gastric suctioning [14; 15]. Mounting evidence 
indicates that nociceptive circuitry is both established and functional during late gestation, and 
that premature infants are indeed capable of mounting developmentally specific and distinct 
responses to noxious and non‐noxious stimuli [16; 17]. Moreover, cortical activation in 
response to acute noxious stimulation in preterm neonates at 25 weeks has been reported, 
suggesting the potential for higher‐level processing of pain [18; 19].  
The Lasting Impact of Neonatal Noxious Stimulation 
Pain is unique amongst sensory modalities. While olfactory, auditory, and tactile stimulation are 
plentiful after birth, the newborn mammalian CNS is rarely exposed to nociceptive input. 
During the last two decades, however, this situation has changed dramatically due to the wide 
application of intensive care interventions in high‐risk preterm neonates [7; 20]. As the 
neonatal period is a sensitive window for experience‐induced plasticity due to the ongoing 
maturation of nociceptive systems [21], accumulating evidence from clinical and animal 
research studies indicates that exposure to noxious stimulation, experienced early in life, can 
leave a legacy of altered somatosensory processing [8; 22; 23; 24; 25; 26; 27].  
Long‐Term Effects of Early Noxious Insult on Developing Nociceptive Systems‐Clinical Studies 
Early pioneering studies on the lasting impact of early life noxious stimulation in human infants 
reported that heel lance elicits decreased facial and enhanced cardiovascular responses, 
indicative of an increased threshold for pain, in preterm infants with prior NICU experience 
compared to age matched full‐term infants [28]. Subsequent studies revealed that a higher 
frequency of invasive procedures in preterm infants is significantly associated with dampened 
nociceptive responses at 32 weeks of age compared to controls [29]. Moreover, decreased 
facial responsiveness to immunization at 4 and 8 months [30], and blunted nociceptive 
sensitivity have been reported in 18 month old former preterm neonates compared to full term 
peers [24]. Former NICU toddlers are also rated by parents as less pain sensitive compared to 
term‐born controls, with a higher frequency of procedural pain exposure associated with more 
dampened nociceptive responsiveness to noxious stimulation at 18 months of age [24]. 
Furthermore, a recent study reported that former extremely preterm children display a 
generalized decrease in thermal but not mechanical nociceptive sensitivity during pre‐
adolescence, suggesting lasting centrally mediated alterations in nociceptive pathways [31].  
In contrast to the aforementioned reduced nociceptive responsiveness following superficial (i.e. 
acute and inflammatory) types of neonatal noxious stimulation, deep somatic and visceral 
noxious stimulation (i.e. early surgery and tissue damage) in infancy leads to prolonged 
sensitization of nociceptive responses. Hypersensitivity to tissue damage is observed in human 
infants, in that a decrease in sensory thresholds is observed for days or weeks in the presence 
of local or deep visceral tissue injury [32; 33]. Furthermore in premature infants, the 
withdrawal reflex threshold in an area of local tissue damage following repeated heel lances is 
half the value of that on the intact contralateral heel for several months following the initial 
insult [34; 35]. Interestingly, this response is not restricted to the site of injury, as former NICU 
infants also display secondary hyperalgesia (sensitivity in surrounding areas of undamaged 
tissue) in the intact, contralateral limb [36]. Similarly, infants that experienced surgery within 
the first three months of life display enhanced hypersensitivity to subsequent surgery 
performed in the same dermatome that persists for more than one year [37]. This 
hypersensitivity is also not restricted to the site of tissue damage, as neonates demonstrate 
greater sensitivity to mechanical stimulation both in the area of incision and on the 
contralateral side of the body following corrective unilateral abdominal surgery [38]. Moreover, 
term‐born males that experienced un‐anesthetized neonatal circumcision respond more 
intensely to routine inoculation at 4‐6 months in comparison to uncircumcised infants; this 
effect is partially attenuated by pre‐treatment with a local anesthetic [39].  
Interestingly, alterations in nociception do not appear to be transient in nature, whereby both 
full‐ and preterm infants with prior NICU experience display an increased threshold for acute 
thermal stimuli (i.e. decreased sensitivity), but enhanced perceptual sensitization to a 
prolonged heat stimulus (i.e. hyper‐sensitivity) up to 14 years of age [31; 40]. Former preterm 
adolescents also display significantly greater tenderness in response to pressure [41], are more 
prone to lasting clinical somatization [40], and report earlier onset of pediatric migraine [42] 
compared to full‐term peers. Indeed, 10‐year old children with former NICU experience also 
rate pictures of medical events as more intense than pictures of psychosocial pain events, 
unlike term‐born children [43]. (See Table 1) 
Long‐Term Effects of Early Noxious Insult on Developing Nociceptive Systems‐Experimental 
Animal Studies 
There is considerable parallel evidence in non‐human animal models that neonatal noxious 
stimulation induces persistent alterations in somatosensory structure and function that last into 
adult life [8; 27; 44]. Data collected to date suggest, however, that the type of noxious 
stimulation (acute: lasting minutes to days, versus tonic: lasting weeks to months) is critical to 
the long‐term impact. Early pioneering studies reported that chronic neonatal inflammation 
induced by unilateral intraplantar application of Complete Freund’s adjuvant results in 
enhanced nociceptive sensitivity, as well as increased primary afferent nerve fiber innervation 
of the spinal cord that extend into adulthood [27]. Similarly, local hindpaw skin wounds induced 
during the first week of life result in long‐lasting cutaneous hypersensitivity, expanded dorsal 
horn receptive fields, and profound sprouting of local sensory nerve terminals in adulthood [27; 
44]. This hyperinnervation is associated with a long‐lasting decrease in mechanical threshold in 
the wounded region, as well as a substantial up‐regulation of growth factors including NGF and 
BDNF [45; 46; 47]. Moreover, repeated intraplantar carrageenan administration over the first 
three postnatal weeks results in enhanced nociceptive sensitivity [26]. Thermal hyperalgesia 
following exposure to repetitive needle pricks, and lasting visceral hyperalgesia associated with 
neonatal chronic chemical irritation of the colon have also been reported [22; 48]. Finally, a 
persistent neonatal lipopolysaccharide immune challenge produces long‐lasting hypersensitivity 
to mechanical and thermal stimuli in adulthood [49].  
In contrast, a generalized decrease in nociceptive sensitivity as a consequence of acute or 
superficial stimulation such as foot shock and intraplantar formalin injections have been 
demonstrated [6; 50]. Likewise, a long‐term global elevation of nociceptive thresholds in 
response to noxious thermal and mechanical stimulation following short‐lasting local neonatal 
inflammation with intraplantar carrageenan has been reported [8]. Remarkably, this 
hypoalgesia is not only present in the neonatally injured hindpaw but is also present in the 
intact contralateral paw. The degree of hypoalgesia produced by the P0 insult is not trivial; paw 
withdrawal latencies increase by more than 40% in adult animals that were injured on the day 
of birth in comparison to control animals.  Injury‐induced hypoalgesia is observed in both 
adolescence (P40) and adulthood (P60), and is significantly greater in neonatally injured 
females compared to injured males [25]. Alternatively, a few studies using similar paradigms 
have failed to report any long‐term effects on sensory thresholds [51; 52]. This may be due to 
variability in the concentration of the inflammatory agents used, as well as additional 
contributing factors that are still not well‐understood. The abovementioned hypoalgesic 
response that we report is also associated with excessive hyperalgesia in the presence of on‐
going inflammation following a subsequent inflammatory insult in adulthood [8], with 
neonatally injured females again exhibiting significantly greater hyperalgesia in the inflamed 
paw than neonatally injured males. While an early study only reported this effect in the 
neonatally inflamed hindpaw [8], we observed enhanced hyperlagesia in both the neonatally 
injured and uninjured paws, which is consistent with previous studies reporting long‐lasting 
sensitization of afferent neurons and hyperalgesia following neonatal insult [22; 46; 48]. These 
inconsistent results may be due to differences in the timing of neonatal injury, adult 
reinflammation and/or behavioral testing.   
This increased hyperalgesia following re‐inflammation in adulthood may appear disparate with 
the observed basal hypoalgesia. Anatomical studies, however, suggest that neonatal 
inflammatory insult results in alterations in primary afferent innervation of the dorsal horn [53], 
which may account for our observed hyperalgesia. In particular, neonatal inflammatory insult 
increases primary afferent innervation in the L3‐L5 spinal cord, as reflected by increased 
expression of both CGRP and substance P immunoreactivity (unpublished observations). 
Parallel changes are not observed in CGRP expression in the thoracic spinal cord of injured 
animals, indicating that these changes are site‐specific. Similar findings of an increase in 
substance P levels in laminae I and II of the dorsal horn have been reported following chronic 
inflammation in rodents [54]. As both CGRP and substance P are pro‐nociceptive, enhanced 
dorsal horn release of these peptides due to increased primary afferent input would be 
associated with an enhanced response to noxious stimulation, and may provide the biological 
basis for the observed increased hyperalgesia following intraplantar CFA in adulthood. The dual 
findings of baseline hypoalgesia and enhanced hyperalgesia following a subsequent insult are 
also surprisingly consistent with previous reports in former premature children. Grunau and 
colleagues found that ex‐preterm neonates are rated by parents as less reactive to everyday 
bumps and scrapes; however parents rate that these children experience medical procedural 
pain as more intense [24; 55]. Similarly, adolescents with prior NICU experience display an 
increased threshold for acute thermal stimuli (i.e. decreased sensitivity), but enhanced 
perceptual sensitization to a prolonged heat stimulus (i.e. hyper‐sensitivity) [40]. Taken 
together, these data suggest that early life exposure to acute versus persistent noxious 
stimulation may differentially affect developing nociceptive circuitry, thereby producing distinct 
long‐term effects. (See Table 2) 
Interestingly, the aforementioned studies suggest that the long‐term impact of neonatal 
noxious insult mirrors the developmental consequences of early life stress. Compelling 
evidence in experimental animal models has revealed that stressful experiences during the 
perinatal period result in profound and permanent consequences on the behavioral and 
neuroendocrine responses to stress stimuli in adulthood. Specifically, exposure to a potent 
stressor such as repeated maternal separation results in lasting hyperactivation of the 
hypothalamic pituitary adrenal (HPA) axis, while brief bouts of handling (i.e. mild stressor in 
rodents) during the perinatal period result in a stress hypo‐responsive phenotype [56; 57; 58]. 
Thus, given that the lasting impact of early life stress on the HPA axis is dependent upon the 
degree (mild versus severe) of perinatal stress exposure, the type of noxious stimulation (acute 
versus tonic), similarly, appears to be critical to the long‐term bivalent effects of neonatal insult 
on baseline nociceptive thresholds.  
Critical Period 
The ability of early life experience to alter the organization of the CNS and subsequent behavior 
is a major focus of neuroscientific research. Previous research in both human and non‐human 
animal models suggests that there are periods during nervous system development within 
which perturbations have long‐lasting, if not permanent consequences. This is in contrast to the 
relatively transient effects associated with the same perturbations at times outside these 
periods [59; 60]. Work in our laboratory has indicated that there is indeed a critical period for 
the long‐term consequences of neonatal inflammatory insult on adult sensory thresholds. 
Animals that experienced unilateral neonatal hindpaw inflammation on both postnatal days 
zero and eight (P0 and P8) display a significant decrease in sensitivity to noxious stimuli 
(hypoalgesia) in adulthood, compared to animals injured at two weeks of age (P14) [25]. 
Together, these results suggest that the impact of neonatal inflammation is dependent upon a 
sensitive period, and that noxious insult occurring outside of this critical window does not 
permanently alter thermal sensory thresholds. These results are consistent with previous 
animal studies that have also reported that neonatal injury permanently alters visceral and 
somatic sensory processing, however, only when induced during the first week of life [8; 10].  
Sex Differences In Response to Neonatal Noxious Stimulation 
Given the sizable body of literature that indicates that males and females experience pain 
differently [61; 62; 63], it is surprising that the majority of previous studies examining the 
impact of neonatal noxious insult have been conducted exclusively in male rodents [8; 26; 27].  
Our laboratory has hypothesized that sexually dimorphic organizational hormones may 
contribute to significant sex differences in response to noxious inflammatory insult [64; 65; 66; 
67]. Sex steroid hormones such as estrogens and androgens modulate prenatal and postnatal 
functional development and have potent influences on pain thresholds in male and female rats 
[68; 69]. Prenatally, males experience a significant surge of testicular testosterone that is 
centrally aromatized to estradiol and ultimately results in the masculinization of the male brain 
[64; 65; 66; 67]. In females, the ovaries are quiescent and intracerebral estradiol remains low at 
birth [64; 65; 66; 67]. Similar differences in hormone levels may also be present in peripheral 
tissues as well. Given that estrogens have been shown to exert neuromodulatory and 
neuroprotective effects following acute and chronic central injuries, increased perinatal central 
estradiol in males may contribute to lasting sexually dimorphic responses to early life noxious 
stimulation [64; 70; 71].  
To our knowledge, we reported for the first time that neonatal inflammatory insult was indeed 
sexually dimorphic, with females displaying significantly greater basal hypoalgesia in adulthood 
in comparison to males. The paw withdrawal latency of females injured with 1% CGN was more 
than 3 seconds longer in both the inflamed and intact hindpaws compared to injured males 
[25]. Moreover, we showed that female rats injured at P14, when estradiol concentrations are 
comparable in males and females, displayed equivalent levels of baseline hypoalgesia as injured 
males. This further suggests that sex differences in the neonatal neuroendocrine environment 
contribute to the observed sexually dimorphic impact of neonatal inflammatory insult [25].  
Estrogen also influences the expression of a number of pro‐inflammatory as well as pro‐
nociceptive agents that may contribute to sex differences in nociceptive responses. For 
example, prostaglandins (which are pro‐inflammatory) are released peripherally in response to 
injury, and estrogen has been shown to modulate both prostaglandin and COX‐1 and COX‐2 
expression in peripheral tissues [72]. In adults, estrogens modulate vascular tone in a tissue 
specific manner (vasodilation, vasoconstriction), which may lead to differences in inflammation‐
induced edema [71]. Peripheral injury also results in increased BDNF that is thought to promote 
neuronal survival and healing. As estradiol increases BDNF expression centrally, this may also 
attenuate the adverse effect of peripheral injury [73]. 
In addition, activational gonadal hormones can alter the processing of nociceptive information. 
Sex‐steroids influence endogenous opioid systems [74; 75], as well as the activity of other 
neuromodulators involved in nociceptive processing; including substance P, gamma‐
aminobutyric acid (GABA), glutamate, dopamine, serotonin and norepinephrine [76; 77]. 
Moreover, gonadal hormones have been shown to have a marked influence on estrous cycle 
effects on nociceptive and analgesic sensitivity in rodents [78; 79], as well as menstrual cycle 
variability in chronic pain conditions such as migraine headache [80], temporomandibular 
disorders [81], and fibromyalgia [82].  
Thus, several mechanisms may contribute to a sexually dimorphic effect of neonatal noxious 
insult, including sex differences in the neuroendocrine environment at the time of injury and/or 
at the time of testing. While there are no reported sex differences in response to early life 
noxious stimulation in premature infants, primarily because of the small sample sizes that are 
unable detect sexual dimorphic effects, the aforementioned studies suggest that the lasting 
impact of procedural pain experienced in the NICU may indeed be sexually dimorphic. In 
addition, all of the previous experimental rodent studies that have examined the lasting 
consequences of neonatal noxious insult on developing nociceptive circuits have been 
conducted exclusively in males. Hence, the inclusion of female subjects in basic and clinical 
research studies examining this topic is warranted, as premature females may be at 
considerably increased risk for long‐term consequences of early life trauma. 
Increased Endogenous Opioid Tone: A Potential Mechanism for the Neonatal Injury‐Induced 
Deficits in Nociceptive Responsiveness 
While the impact of neonatal noxious stimulation on developing nociceptive circuitry and 
subsequent pain processing and perception has been the focus of a significant amount of 
research within the last decade, clinical and experimental studies have failed to elucidate the 
mechanisms underlying the reported lasting alterations in nociceptive responsiveness. The 
periaqueductal gray (PAG), and its descending projections to the rostral ventromedial medulla 
(RVM) and the spinal cord dorsal horn, constitute a primary anatomical circuit for the 
descending modulation of pain [83]. The PAG is rich in nerve terminals and fibers containing 
endogenous opioids [84], and opioid receptors are localized throughout the rostral‐caudal axis 
of the PAG [85]. Interestingly, while in rats the anatomical connections for nociceptive 
modulation are present at birth, descending inhibitory controls are functionally immature 
throughout the first postnatal weeks [86; 87]. The delayed maturation of descending inhibition 
may therefore contribute to the increased vulnerability of the immature somatosensory system 
to excessive afferent input, whereby exposure to neonatal noxious stimulation during a critical 
window may alter the functional integrity of endogenous descending inhibitory systems. 
Indeed, our laboratory hypothesized that neonatal injury during this critical developmental 
period (P0‐P8) [25] results in increased afferent drive to CNS sites responsive to noxious input 
(eg. PAG). This increased drive results in the activation of endogenous pain inhibitory circuits 
and the subsequent release of endogenous opioid peptides. As the inflammation associated 
with intraplantar carrageenan is persistent (lasting approximately 24‐48 hours), the release of 
endogenous opioids is sustained, and this continuous opioid release, during a time of increased 
developmental plasticity, is subsequently maintained into adulthood. This is supported by 
mounting behavioral data [8; 25]. Specifically, the observable hypoalgesia following neonatal 
injury is limb non‐specific (present in both the forepaws and hindpaws) and global in nature 
(somatic and visceral) [10; 25]. Therefore, it appears to involve multiple segmental levels of the 
spinal cord, various dermatomes, and occurs bilaterally. Indeed these results are not easily 
explained by the induced unilateral neonatal insult that impacts few ipsilateral spinal levels. 
Consequently, the hypoalgesia appears better explained by alterations in descending 
nociceptive circuitry, such as that arising from the PAG, that produce global, limb‐non‐specific 
analgesia along the entire axis when activated.  
Parallel studies have reported that increased afferent drive during the developmental critical 
period results in the reorganization of somatosensory circuits in adulthood, and interestingly, 
changes in endogenous pain modulation in humans as a consequence of neonatal pain has 
been previously proposed to account for the long term changes in pain sensitivity observed in 
NICU infants exposed to frequent noxious interventions [88].  
We have recently reported a significant increase in PAG opioid peptide expression (beta‐
endorphin and met/leu‐enkephalin) as a consequence of neonatal injury [89]. It was notable 
that alterations in the endorphin and enkephalinergic systems were very well correlated across 
similar regions and levels of the PAG, suggesting that the two opioidergic systems act in parallel 
in response to neonatal inflammation and nociception. While comparable studies cannot be 
conducted in neonates, previous studies in adult rats have also reported that hindpaw 
inflammation results in upregulated biosynthesis of pro‐dynorphin and pro‐enkephalin in dorsal 
horn neurons [90; 91], and a significant increase in endogenous opioid peptide release within 
the PAG [92]. Noxious stimulation‐induced changes in opioid peptide expression are also 
paralleled by an increase in mRNA expression [90]. As stated above, our working hypothesis is 
that neonatal inflammation results in the release of endogenous opioid peptides within the 
PAG as a mechanism of decreasing nociception. Surprisingly, a parallel decrease in opioid 
receptor expression was also noted. Previous studies have similarly reported a long‐term 
increase in endogenous opioid peptide along with a concomitant decrease in mu and delta 
opioid receptor density in the lateral hypothalamus of offspring following gestational stress [93; 
94]. Alternatively, however, opioid receptors are rapidly internalized following ligand binding, 
which would also result in a concomitant decrease in opioid receptor availability. Taken 
together, these studies suggest that early life stressors can confer long‐lasting changes in 
supraspinal opioidergic circuits that are reflected by changes in peptide and receptor 
expression. Interestingly, we reported a significantly greater increase in met‐enkephalin 
observed in neonatally injured females compared to males. This differential change in peptide 
expression may contribute to the increased hypoalgesia observed in females [25]. No significant 
sex difference in met‐enkephalin immunoreactivity was present at baseline, indicating that the 
observed sex differences were injury‐induced. In parallel behavioral studies, we found that 
intra‐PAG administration of the opioid antagonist naloxone significantly reduced neonatal 
injury‐induced hypoalgesia, further implicating the PAG as the primary site whereby neonatal 
injury permanently alters somatosensory processing [89].  
While these results strongly suggest that persistent alterations in baseline nociceptive 
thresholds associated with neonatal inflammatory insult are mediated by a central increase in 
endogenous opioid tone, additional mechanisms may also contribute. Previous studies have 
demonstrated that early life insult also results in increased serotonergic receptor expression in 
the PAG [95], as well as upregulated GABA, serotonin, opioid, neuropeptide Y, tachykinin and 
interleukin systems at the spinal level [96]. Therefore, a multitude of alterations at the levels of 
the brain and spinal cord may contribute to the observable behavioral alterations in adulthood 
following neonatal noxious insult.  
Additionally, noxious neonatal experiences lead not only to decreased nociceptive sensitivity in 
adulthood, but also to significant alterations in the behavioral and neuroendocrine responses to 
stress [6; 22; 97; 98; 99; 100]. Blunted emotionality, decreased anxiety, and reduced basal and 
stress induced plasma corticotropin releasing factor (CRF) and adrenocorticotropin hormone 
(ACTH) are displayed in adult rats following short‐lasting, local inflammation experienced during 
the first week of life [6; 95]. Premature infants with extensive NICU care also exhibit low basal 
levels of stress hormones at 3 months of age compared to their full‐term counterparts [101]. 
Thus, alterations in the developing hypothalamic‐pituitary‐adrenal axis may also contribute to 
the long‐term basal hypoalgesia following neonatal hindpaw inflammation. Indeed, our 
preliminary data suggests that neonatal noxious stimulation produces a generalized reduction 
in reactivity to non‐life threatening aversive environmental stimuli due to parallel alterations in 
supraspinal nociceptive and stress modulatory circuits [8; 95]. For example, neonatally injured 
male and female rats tested in adulthood display reduced anxiety in the open field and elevated 
plus maze, as indicated by an increase in time spent in the open areas.  By contrast, in the 
forced swim test, injured animals display significantly shorter latencies to immobility suggesting 
a hyper‐response to a strong physiological stressor (unpublished observations). Furthermore, 
corticosterone (CORT) levels were significantly blunted in injured females at baseline and 
following restraint stress. Anseloni et al [85] similarly reported that neonatally‐injured animals 
displayed reduced anxiety behavior, however found increased latency to immobility to the 
forced swim test.  The reasons for the discrepant results are not known, but may include 
differences in the type of injury paradigm employed, or in the age at the time of injury. 
Regardless, together these studies indicate that neonatal injury alters adulthood stress and 
anxiety‐related behaviors in a sexually dimorphic manner, and contributes to mounting 
evidence that neonatal trauma in the absence of analgesics has long‐term polysystemic adverse 
effects. 
Clinical Implications for Changes in Endogenous Opioid Tone 
Our studies have shown that persistent pain experienced early in life results in decreased mu 
and delta receptor availability, suggesting a persistent activation of opioid receptors due to 
enhanced release of endogenous opioid peptides. This decrease in receptor availability is 
supported by our previous findings demonstrating a significant rightward shift in the morphine 
dose‐response curve in adult animals that were injured neonatally [102]. Similar results have 
been reported in children, in that the number of invasive procedures experienced in the 
neonatal intensive care unit are inversely correlated with morphine effectiveness [29]. Despite 
the current knowledge that neonates are responsive to noxious stimuli, the majority of routine 
procedures, including repeated heel‐lances, endotracheal intubations and minor surgeries are 
performed in the absence of analgesics [15]. Indeed recent studies have reported that neonates 
receiving NICU treatment experience an average of 14 noxious procedures per day, with fewer 
than 35% receiving appropriate analgesic therapy [15]. The findings that neonatal injury results 
in long‐term changes in opioid tone and hypoalgesia have serious implications for future pain 
management in neonates.   
Effects Of Analgesia On Developing Nociceptive Circuitry 
Despite the current knowledge that preterm infants are responsive to noxious stimulation [17; 
103; 104] and the accumulating evidence that invasive procedures can have lasting effects on 
developing nociceptive circuitry, neonatal pain remains an under‐recognized and under‐treated 
condition in the NICU [15; 105; 106]. Indeed, many life‐saving intensive care interventions are 
performed in the absence of analgesics [15; 105; 106; 107].  
Conflicting evidence exists as to the clinical benefits of opioid analgesia in premature infants 
undergoing invasive procedures in the NICU [29; 108; 109; 110; 111]. For example, altered pain 
responses in former preterm neonates can be predicted by the number of previous painful 
procedures and are normalized by the early use of morphine as an analgesic [29]. In addition, 
post‐operative morphine analgesia in preterm and full‐term infants reduces behavioral and 
hormonal stress responses [112; 113; 114] and is associated with decreased mortality [115; 
116]. Furthermore, 45 month‐old children that experienced operations following pre‐emptive 
analgesia during early life respond to immunization pain in a similar manner as non‐operated 
age‐matched controls [117]. Lastly, the long‐term outcomes at 5‐6 years of age of formerly 
preterm children who were exposed to morphine in the neonatal period indicate no adverse 
effects of morphine on intelligence, motor function, cognitive development or other behavioral 
outcomes [29; 30; 110; 118]. 
Alternatively, morphine is not recommended as a standard of care for acute pain resulting from 
invasive procedures in ventilated preterm newborns [119; 120]. Further conflicting evidence 
exists on the long‐term effects of early opiate exposure on later cognitive and motor abilities in 
preterm infants. Specifically, higher morphine exposure is associated with poorer motor 
development at 8 months, but not 18 months of age [109]. Similarly, neonatal morphine 
analgesia contributes to subtle neurobehavioral differences, including altered motor function, 
in preterm infants at 36 weeks [111]. Parallel evidence in rodents suggests delays in motor 
development following early morphine exposure [121], and a recent study demonstrated 
marked learning impairments in passive avoidance and forced swim tasks in adulthood 
following neonatal exposure to opiates [122].  
Clearly, the aforementioned studies imply the importance of additional research to evaluate 
both the short‐term and long‐term effects of morphine analgesia on the neurobehavioral 
outcomes of prematurity, specifically the impact of neonatal opiate exposure on motor and 
cognitive development. Further studies examining the effects of pre‐emptive analgesics in the 
NICU are challenging, however, as the humane care of infants requires physicians to treat those 
perceived to be in distress. As such, the gaps in our knowledge of the long‐term risks and 
benefits of analgesic therapy in newborns would greatly benefit from experimental animal 
models, as very few studies have examined whether opioid analgesics can be used to prevent 
the long‐term sequelae associated with neonatal noxious insult [100]. 
We have previously demonstrated that pre‐emptive morphine administration blocks neonatal 
injury induced thermal and mechanical hypoalgesia in both the injured and uninjured paws in 
adolescence (P40) and adulthood (P60) [99]. Moreover, morphine attenuation of the 
hypoalgesia was reported to be comparable in males and females [90]. These results are 
consistent with previous studies in rodents that report daily morphine administration prior to 
intraplantar formalin during the first week of life significantly reduces the long‐term effects of 
repetitive pain [123]. Previous studies in humans have also reported that morphine therapy 
ameliorates the effects of early repetitive noxious stimuli in extremely low birth weight infants 
at 4 months of age [29]. Similarly, children who had minor neonatal operations and received 
pre‐emptive analgesia responded to immunization pain in a similar manner as non‐operated 
age‐matched controls [117]. The ability of pre‐emptive morphine to block the hypoalgesia may 
indeed occur through direct modulation of primary afferent drive into the spinal cord, thereby 
inhibiting the central relay of inflammatory pain and preventing the subsequent increase in 
descending endogenous opioid tone [99]. However, the effects of morphine in these studies 
may partly be a consequence of modification of the inflammatory response and/or the stress 
response to neonatal inflammatory insult [124; 125].  
Neonatal morphine has also been shown to significantly attenuate CFA‐ induced hyperalgesia 
and increased the rate of recovery, such that both males and females recover 7 days faster than 
saline treated injured controls [99]. As previously stated, increased primary afferent innervation 
of the spinal cord dorsal horn following neonatal inflammatory insult may account for our 
observed hyperalgesia in adulthood [25]. Administration of morphine at the time of injury 
would be expected to inhibit this increase in primary afferent input, thereby preventing the 
entire cascade of behavioral, physiological and anatomical deficits associated with neonatal 
inflammation.  In regard to recovery, clinical reports demonstrate that at 32 weeks of age, 
preterm infants experience a reduced rate of recovery to skin breaking procedures [126], and 
exhibit subtle differences in ability to recover from finger lance at 4 months compared to full 
term controls [30]. There are no reports on the impact of pre‐emptive morphine on recovery 
rates in premature neonates; however, these data suggest that morphine analgesia may in fact 
significantly increase the rate of recovery following procedural pain in NICU infants.  
While neonatal morphine administration does not significantly alter morphine’s antinociceptive 
effects in adulthood in males or females (i.e. no significant shift in ED50 values), interestingly, a 
significant rightward shift in ED50 is noted in neonatally injured animals that do not receive 
neonatal morphine [99]. These results have serious clinical implications. Previous studies have 
reported that pre‐term infants that experience surgery during the first three months of life 
have significantly higher peri‐ and post‐operative analgesic requirements in response to surgery 
in the same or different dermatome compared to control infants [37; 114]. Similarly, mice 
exposed to chronic noxious stimulation display increased tail flick latencies compared to control 
animals, and a significant two‐fold increase in the ED50 of morphine in response to abdominal 
constriction [127]. As noxious stimulation during the neonatal period leads to increased 
activation of opioid systems in a manner analogous to the repeated application of exogenous 
opiates, these studies suggest that neonatal injury produces cross‐tolerance to the analgesic 
effects of morphine thereby decreasing the subsequent effectiveness of morphine [128; 129; 
130]. Again interestingly, exposure to morphine neonatally does not result in a significant shift 
in ED50 values. Therefore, it appears that opioid cross tolerance may be associated with 
neonatal injury‐induced chronic exposure to endogenous opioids resulting from a potentiation 
of the descending inhibitory circuit, and not a result of exposure to morphine on P0. 
Alternatively, neonatal stress associated with maternal separation and repeated handling has 
also been suggested to reduce opioid analgesia [99; 131]. This suggests that alterations in 
opioid analgesia may reflect a combined effect of neonatal nociceptive experience as well as 
early life stress, and may involve altered responsiveness of endogenous analgesia circuits as 
well as the hypothalamic‐pituitary‐adrenal axis [4]. 
Final Remarks 
Although research into the long‐term consequences of noxious stimulation during the neonatal 
period have spanned over two decades, our understanding of neonatal pain is literally still in its 
infancy. The studies presented in this review have established that exposure to neonatal 
noxious insult is associated with a lasting alteration in both basal nociceptive sensitivity and 
response to a subsequent injury in adulthood (See Figure 1). Moreover, the impact of neonatal 
injury appears to be significantly exacerbated in females in comparison to males. The clear 
presence of a sex difference in the response to early insult may indeed contribute to the higher 
prevalence, severity and duration of pain syndromes observed in women than men. 
Furthermore, the profound alterations of nociceptive thresholds following neonatal 
inflammation may be mediated by an experience‐induced facilitated activation of descending 
nociceptive pathways, characterized by dynamic physiological and anatomical modification and 
modulation of opioidergic systems in the PAG. Finally, pre‐emptive analgesia has been shown to 
ameliorate the long‐term effects of neonatal injury on adult nociception, which provides 
compelling justification for the use of analgesics prior to the initiation of noxious procedures 
performed on neonates. Collectively, these studies present valuable information about the 
long‐term consequences of neonatal noxious stimulation, which may ultimately lead to 
improved understanding and treatment of the lasting effects of repeated invasive interventions 
in premature infants in the NICU. 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Figure 1 The Lasting Impact of Neonatal Inflammatory Insult: A Summary.  
(A) Intraplantar carrageenan (CGN) on the day of birth (P0) results in (B: left‐handled; right‐1% 
CGN) a lasting increase in primary afferent innervation of the dorsal horn of the lumbar spinal 
cord, ultimately leading to (C) an increase in endogenous opioid tone which is characterized by 
(D: top left‐met enkephalin handled; top right‐met enkephalin 1% CGN; bottom right‐beta 
endorphin 1% CGN; bottom left‐beta endorphin handled) a significant increase in enkephalin 
and beta endorphin immunoreactivity and (E: top left‐MOR handled; top right‐MOR 1% CGN; 
bottom right‐DOR 1% CGN; bottom left‐DOR handled) a significant decrease in mu and delta 
opioid receptor binding in the PAG. This increase in opioid tone contributes to the (F) observed 
hypoalgesia at baseline testing. (G) In the presence of a subsequent major noxious insult in 
adulthood, (H: left‐handled; right‐1% CGN) neonatally injured animals have increased release of 
pro‐nociceptive peptides (i.e. CGRP and substance P) compared to handled animals, resulting in 
(I) enhanced hyperalgesia following intraplantar CFA. 
 
